Good clinical practices in monitoring antihypertensive clinical trials
نویسندگان
چکیده
منابع مشابه
Ambulatory blood pressure monitoring in clinical trials with antihypertensive agents.
Ambulatory blood pressure monitoring (ABPM) is being used increasingly for the evaluation of antihypertensive agents in clinical trials. In this brief review several aspects of ABPM are discussed. In particular, attention is paid to the extent to which ABPM is subject to a placebo response and the extent to which the sample size of the study population can be reduced with this type of measureme...
متن کاملNovel ocular antihypertensive compounds in clinical trials
INTRODUCTION Glaucoma is a multifactorial disease characterized by progressive optic nerve injury and visual field defects. Elevated intraocular pressure (IOP) is the most widely recognized risk factor for the onset and progression of open-angle glaucoma, and IOP-lowering medications comprise the primary treatment strategy. IOP elevation in glaucoma is associated with diminished or obstructed a...
متن کاملSponsorship in non-commercial clinical trials: definitions, challenges and the role of Good Clinical Practices guidelines
BACKGROUND Non-commercial clinical research plays an increasingly essential role for global health. Multiple partners join in international consortia that operate under the limited timeframe of a specific funding period. One organisation (the sponsor) designs and carries out the trial in collaboration with research partners, and is ultimately responsible for the trial's scientific, ethical, reg...
متن کاملClinical trials: towards good practice.
Quality control, quality assurance, and audit are now an integral, though not always welcome, part of our daily lives. For many years the conduct of clinical trials has relied heavily on trust and the integrity of those involved, and the amount of regulation has been minimal. The introduction of the Declaration of Helsinki in 1964 spelt out the ethical considerations but further changes over th...
متن کاملMonitoring clinical trials.
Editor—Lilford et al make a case that interim analyses from randomised trials should be shared with participants and doctors and patients. These analyses should be shared for the sake of freedom of information and properly informed consent, as a counterweight to paternalism, for the better public understanding of uncertainty, and regardless of drug regulatory or financial considerations. But th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Hypertension
سال: 1999
ISSN: 0895-7061
DOI: 10.1016/s0895-7061(99)80399-9